ACM

Aisling Capital Management Portfolio holdings

AUM $360M
This Quarter Return
+22.13%
1 Year Return
+114.67%
3 Year Return
+1,171.46%
5 Year Return
+892.24%
10 Year Return
–
AUM
$282M
AUM Growth
+$282M
Cap. Flow
-$9.37M
Cap. Flow %
-3.33%
Top 10 Hldgs %
98.41%
Holding
16
New
–
Increased
1
Reduced
1
Closed
1

Top Buys

1
MRKR icon
Marker Therapeutics
MRKR
$34.5K

Top Sells

1
OKUR
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$6.86M
2
TECX
Tectonic Therapeutic, Inc. Common Stock
TECX
$2.55M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BBIO icon
1
BridgeBio Pharma
BBIO
$9.89B
$167M 59.08%
6,068,125
– –
VRNA
2
Verona Pharma
VRNA
$9.16B
$51.8M 18.38%
1,115,352
– –
SNDX icon
3
Syndax Pharmaceuticals
SNDX
$1.41B
$13.6M 4.81%
1,025,000
– –
GLUE icon
4
Monte Rosa Therapeutics
GLUE
$296M
$10.2M 3.63%
1,472,331
– –
PSTX
5
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$10M 3.55%
1,043,267
– –
BCAX
6
Bicara Therapeutics Inc. Common Stock
BCAX
$651M
$9.91M 3.52%
568,919
– –
NUVB icon
7
Nuvation Bio
NUVB
$1.02B
$6.76M 2.4%
2,541,009
– –
CMPS
8
Compass Pathways
CMPS
$424M
$3.65M 1.29%
964,500
– –
BMEA icon
9
Biomea Fusion
BMEA
$116M
$3.1M 1.1%
798,757
– –
CALC icon
10
CalciMedica
CALC
$37.7M
$1.84M 0.65%
521,114
– –
ELEV
11
DELISTED
Elevation Oncology
ELEV
$1.59M 0.56%
2,834,910
– –
ACRS icon
12
Aclaris Therapeutics
ACRS
$209M
$1.08M 0.38%
434,455
– –
MRKR icon
13
Marker Therapeutics
MRKR
$12M
$1.01M 0.36%
325,370
+11,084
+4% +$34.5K
OKUR
14
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$37.2M
$762K 0.27%
88,607
-797,468
-90% -$6.86M
VIRX
15
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$46.2K 0.02%
288,571
– –
TECX
16
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
– –
-84,148
Closed -$2.55M